Thus, we argue that bioenergetic collapse, together with reduced pyruvate flux to the TCA cycle, accounts for the dramatic antineoplastic efficacy of HEX against ENO1-deleted gliomas and that glutamine oxidation may not be obligatory for tumor sustenance in vivo. The gene discussed is ENO1; the disease is glioma.